A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumorsJean‐Charles Soria, Michael Millward, Sarah P. Blagden et al.|Annals of Oncology|2016Cited by 145
Dependence on Endocytic Receptor Binding via a Minimal Binding Motif Underlies the Differential Prognostic Profiles of SerpinE1 and SerpinB2 in CancerBlake J. Cochran, Marie Ranson|Journal of Biological Chemistry|2011Cited by 20